Serum insulin-like growth factor-I levels and potential risk of type 2 diabetes

Hormone Research

Volumn 60, Issue SUPPL. 3, 2003, Pages 131-135

  Dunger, D B ^a   Ong, K K L ^a   Sandhu, M S ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Insulin secretion; Insulin sensitivity; Insulin like growth factor binding proteins; Insulin like growth factors; Size at birth; Type 2 diabetes

Indexed keywords

GROWTH HORMONE; SOMATOMEDIN C;

COHORT ANALYSIS; CONFERENCE PAPER; GENE; GENE DELETION; GENETIC LINKAGE; GENETIC POLYMORPHISM; GESTATIONAL AGE; GLUCOSE INTOLERANCE; GROWTH RETARDATION; HEREDITY; HORMONAL THERAPY; HORMONE ACTION; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; KNOCKOUT GENE; KNOCKOUT MOUSE; LOW BIRTH WEIGHT; METABOLIC DISORDER; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; POSTNATAL GROWTH; PRIORITY JOURNAL; PROTEIN INTERACTION; RISK FACTOR; SIDE EFFECT; TREATMENT OUTCOME;

ANIMALS; BLOOD GLUCOSE; COHORT STUDIES; DIABETES MELLITUS, TYPE 2; HUMANS; INFANT, NEWBORN; INFANT, SMALL FOR GESTATIONAL AGE; INSULIN-LIKE GROWTH FACTOR I; LONGITUDINAL STUDIES; POLYMORPHISM, GENETIC; RISK;

EID: 0346749731     PISSN: 03010163     EISSN: None     Source Type: Journal    
DOI: 10.1159/000074514     Document Type: Conference Paper

References (38)

1. Yakar S, Liu JL, Fernandez AM, Wu Y, Schally AV, Frystyk J, Chernausek SD, Mejia W, Le Roith D: Liver-specific igf-1 gene deletion leads to muscle insulin insensitivity. Diabetes 2001;50:1110-1118.
2. Sjögren K, Wallenius K, Liu JL, Bohlooly YM, Pacini G, Svensson L, Tornell J, Isaksson OG, Ahrén B, Jansson JO, Ohlsson C: Liver-derived IGF-I is of importance for normal carbohydrate and lipid metabolism. Diabetes 2001;50:1539-1545.
3. Mortensen DL, Won WB, Siu J, Reifsnyder D, Gironella M, Etcheverry T, Clark RG: Insulin-like growth factor binding protein-1 induces insulin release in the rat. Endocrinology 1997;138:2073-2080.
4. Crossey PA, Jones JS, Miell JP: Dysregulation of the insulin/IGF binding protein-1 axis in transgenic mice is associated with hyperinsulinemia and glucose intolerance. Diabetes 2000;49:457-465.
5. Woods KA, Camacho-Hubner C, Bergman RN, Barter D, Clark AJ, Savage MO: Effects of insulin-like growth factor I (IGF-I) therapy on body composition and insulin resistance in IGF-I gene deletion. J Clin Endocrinol Metab 2000;85:1407-1411.
6. Acerini CL, Harris DA, Matyka KA, Watts AP, Umpleby AM, Russell-Jones DL, Dunger DB: Effects of low-dose recombinant human insulin-like growth factor-I on insulin sensitivity, growth hormone and glucagon levels in young adults with insulin-dependent diabetes mellitus. Metabolism 1998;47:1481-1489.
7. Hussain MA, Schmitz O, Mengel A, Keller A, Christiansen JS, Zapf J, Froesch ER: Insulin-like growth factor I stimulates lipid oxidation, reduces protein oxidation, and enhances insulin sensitivity in humans. J Clin Invest 1993;92:2249-2256.
8. Dunger DB, Acerini CL: Does recombinant human insulin-like growth factor-I have a role in the treatment of diabetes? Diabetic Med 1997;14:723-731.
9. Withers DJ, Burks DJ, Towery HH, Altamuro SL, Flint CL, White MF: Irs-2 coordinates Igf-1 receptor-mediated beta-cell development and peripheral insulin signalling. Nat Genet 1999;23:32-40.
10. Hales CN, Barker DJ: The thrifty phenotype hypothesis. Br Med Bull 2001;60:5-20.
11. Forsen T, Eriksson J, Tuomilehto J, Reunanen A, Osmond C, Barker D: The fetal and childhood growth of persons who develop type 2 diabetes. Ann Intern Med 2000;133:176-182.
12. Brown DC, Byrne CD, Clark PM, Cox BD, Day NE, Hales CN, et al: Height and glucose tolerance in adult subjects. Diabetologia 1991;35:698-699.
13. Ong KK, Ahmed ML, Emmett PM, Preece MA, Dunger DB, the ALSPAC Study Team: Association between postnatal catch-up growth and obesity in childhood: Prospective cohort study. Br Med J 2000;320:967-971.
14. Ong KK, Ahmed ML, Sherriff A, Woods KA, Watts A, Golding J, et al: Cord blood leptin is associated with size at birth and predicts infancy weight gain in humans. J Clin Endocrinol Metab 1999;84:1145-1148.
15. Ong KK, Petry CJ, Emmett PM, Sandhu MS, Watts A, Kiess WI, Hales CN, Ness A, Dunger DB, the ALSPAC Study team: Insulin sensitivity and secretion in normal children related to size at birth, postnatal growth, and plasma insulin-like growth factor-I levels. American Diabetes Association 63rd Scientific Sessions, New Orleans, La., 2003, 0244 (abstract).
16. Kahn SE: The importance of beta-cell failure in the development and progression of type 2 diabetes. J Clin Endocrinol Metab 2001;86:4047-4058.
17. Rahier J, Wallon J, Henquin JC: Cell populations in the endocrine pancreas of human neonates and infants. Diabetologia 1981;20:540-546.
18. Sandhu MS, Heald AH, Gibson JM, Cruickshank JK, Dunger DB, Wareham NJ: Circulating concentrations of insulin-like growth factor-I and development of glucose intolerance: A prospective observational study. Lancet 2002;359:1740-1745.
19. Vaessen N, Heutink P, Janssen JA, Witteman CM, Testers L, Hofman A, Lamberts SW, Oostra BA, Pols HA, van Duijn CM: A polymorphism in the gene for IGF-I: Functional properties and risk for type 2 diabetes and myocardial infarction. Diabetes 2001;50:637-642.
20. Arends N, Johnston L, Hokken-Koelega A, van Duijn C, de Ridder M, Savage M, Clark A: Polymorphism in the IGF-I gene: Clinical relevance for short children born small for gestational age (SGA). J Clin Endocrinol Metab 2002;87:2720-2723.
21. Vaessen N, Janssen JA, Heutink P, et al: Association between genetic variation in the gene for insulin-like growth factor-I and low birthweight. Lancet 2002;359:1036-1037.
22. Frayling TM, Hattersley AT, McCarthy A, Holly J, Mitchell SM, Gloyn AL, Owen K, Davies D, Smith GD, Ben-Shlomo Y: A putative functional polymorphism in the IGF-I gene: Association studies with type 2 diabetes, adult height, glucose tolerance, and fetal growth in UK populations. Diabetes 2002;51:2313-2316.
23. Day IN, King TH, Chen XH, Voropanov AM, Ye S, Syddall HE, Sayer AA, Cooper C, Barker DJ, Phillips DI: Insulin-like growth factor-I genotype and birthweight. Lancet 2002;360:945.
24. Frayling TM, Hattersley AT, Smith GD, Ben-Shlomo Y: Conflicting results on variation in the IGF-I gene highlight methodological considerations in the design of genetic association studies. Diabetologia 2002;45:1605-1606.
25. Dahlman I, Eaves IA, Kosoy R, Morrison VA, Heward J, Gough SC, et al: Parameters for reliable results in genetic association studies in common disease. Nat Genet 2002;30:149-150.
26. McCance DR, Pettitt DJ, Hanson RL, Jacobsson LT, Knowler WC, Bennett PH: Birth weight and non-insulin dependent diabetes: Thrifty genotype, thrifty phenotype, or surviving small baby genotype? Br Med J 1994;308:942-945.
27. Lucas A, Fewtrell MS, Cole TJ: Fetal origins of adult disease - the hypothesis revisited. Br Med J 1999;319:245-249.
28. Albertsson-Wikland K, Boguszewski M, Karlberg J: Children born small-for-gestational age: Postnatal growth and hormonal status. Horm Res 1998;49(suppl 2):7-13.
29. Jaquet D, Gaboriau A, Czernichow P, Lévy-Marchal C: Insulin resistance early in adulthood in subjects born with intrauterine growth retardation. J Clin Endocrinol Metab 2000;85:1401-1406.
30. Veening MA, Van Weissenbruch MM, Delemarre-Van De Waal HA: Glucose tolerance, insulin sensitivity, and insulin secretion in children born small for gestational age. J Clin Endocrinol Metab 2002;87:4657-4661.
31. Woods KA, van Helvoirt M, Ong KK, Mohn A, Levy JC, de Zegher F, Dunger DB: The somatotropic axis in short children born small for gestational age: Relation to insulin resistance. Pediatr Res 2002;51:76-80.
32. Ogilvy Stuart AL, Hands SJ, Adcock CJ, Holly JM, Matthews DR, Mohamed Ali V, Yudkin JS, Wilkinson AR, Dunger DB: Insulin, insulin-like growth factor I (IGF-I), IGF-binding protein-1, growth hormone, and feeding in the newborn. J Clin Endocrinol Metab 1998;83:3550-3557.
33. Chatelain PG, Niccolino M, Claris O, Salle B, Chaussain JL: Multiple hormone resistance in short children born with intrauterine growth retardation? Horm Res 1998;49:20-22.
34. de Zegher F, Ong KK, van Helvoirt M, Mohn A, Woods KA, Dunger DB: High dose growth hormone (GH) treatment in non-GH-deficient children born small for gestational age induces growth responses related to pretreatment GH secretion and associated with a reversible decrease in insulin sensitivity. J Clin Endocrinol Metab 2002;87:148-151.
35. Yoshihashi H, Maeyama K, Kosaki R, Ogata T, Tsukahara M, Goto Y, Hata J, Matsuo N, Smith RJ, Kosaki K: Imprinting of human GRB10 and its mutations in two patients with Russell-Silver syndrome. Am J Hum Genet 2000;67:476-482.
36. de Zegher F, Albertsson-Wikland K, Wollmann HA, Chatelain P, Chaussain JL, Lofstrom A, Jonsson B, Rosenfeld RG: Growth hormone treatment of short children born small for gestational age: Growth responses with continuous and discontinuous regimens over 6 years. J Clin Endocrinol Metab 2000;85:2816-2821.
37. Boguszewski M, Jansson C, Rosberg S, Albertsson-Wikland K: Changes in serum insulin-like growth factor I (IGF-I) and IGF-binding protein-3 levels during growth hormone treatment in prepubertal short children born small for gestational age. J Clin Endocrinol Metab 1996;81:3902-3908.
38. Hokken-Koelega AC, Sas T, van Pareren Y: Effects of long-term GH treatment on insulin sensitivity and glucose tolerance. J Pediatr Endocrinol Metab 2002;15(suppl 5):1277-1278.